Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Menu Back to Committee

Meet the Programme Commitee for DIA Europe 2024!

Program Committee

  • Aimad  Torqui
    Aimad Torqui Head of Division Medicines Evaluation Board
    MEB, Netherlands
  • Álmath  Spooner, PhD
    Álmath Spooner, PhD Head of Europe Regulatory Policy
    AbbVie, Ireland
  • Claudia  Dollins, PhD, RAC
    Claudia Dollins, PhD, RAC Vice President, Precision Medicines, Global Regulatory Affairs
    GlaxoSmithKline, United States
  • Dima  Samaha
    Dima Samaha Senior Principal, EMEA Value & Payer Evidence
    IQVIA, United Kingdom
  • Douglas  Gregory
    Douglas Gregory Senior Director, Government Affairs Strategy and Excellence
    Bristol Myers Squibb, Belgium
  • Esther  De Vries, MSc
    Esther De Vries, MSc Pharmacovigilance Assessor
    CBG-MEB, Netherlands
  • Emma  Du Four, MBA
    Emma Du Four, MBA Regulatory and R&D Policy Professional
    -, United Kingdom
  • James  Whitehead, MBA, MSc
    James Whitehead, MBA, MSc Senior Director, Device & Digital Safety
    AstraZeneca, United Kingdom
  • James  Ryan, MSc
    James Ryan, MSc Global Director, HTA Policy
    AstraZeneca (Global), UK, United Kingdom
  • Julie  O'Brien, PhD
    Julie O'Brien, PhD EFPIA; Senior Director, Head EuCANZ Regulatory Policy
    Pfizer Inc, Ireland
  • Marianne  Lunzer, DrMed
    Marianne Lunzer, DrMed Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care
    AGES, Austria
  • Matt  Popkin, PhD
    Matt Popkin, PhD Senior Director, CMC Excellence, Global Regulatory Affairs
    GlaxoSmithKline, United Kingdom
  • Michela  Gabaldo, PharmD, MSc
    Michela Gabaldo, PharmD, MSc VP ATMP Global Regulatory Affairs
    Evotec, Italy
  • Mireille  Muller, DrSc, PhD, MSc
    Mireille Muller, DrSc, PhD, MSc Regulatory Policy & Intelligence Director
    Novartis Pharma AG, Switzerland
  • Momir  Radulovic
    Momir Radulovic Executive Director
    Slovenian Medicines and Medical Devices Agency (JAZMP), Slovenia
  • Rabia  Sucu
    Rabia Sucu Senior Technical Advisor
    Management Sciences for Health, Ukraine
  • Rodrigo  Palacios, MBA
    Rodrigo Palacios, MBA Regulatory Policy Lead
    F. Hoffmann-La Roche, Switzerland
  • Ronnie Harprit Mundair
    Ronnie Harprit Mundair Regional Labelling Head - AfME, Canada and LATAM - Senior Director
    Pfizer, United Kingdom
  • Sabine  Haubenreisser, PhD, MSc
    Sabine Haubenreisser, PhD, MSc Principal Scientific Administrator, Stakeholders and Communication Division
    European Medicines Agency, Netherlands
  • Sini  Eskola, MPharm, MS, MSc
    Sini Eskola, MPharm, MS, MSc Director Regulatory Affairs
    EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium
  • Sofia  Ribeiro
    Sofia Ribeiro Head Regulatory Affairs CMC
    Bayer US LLC, United States
  • Sophie  Schmitz
    Sophie Schmitz Managing Partner
    P4A Partners for Access, Netherlands
  • Thomas W. Moller, MBA, MSc
    Thomas W. Moller, MBA, MSc Director Global Regulatory Affairs - Devices
    Novo Nordisk, Denmark
  • Tim  Chesworth
    Tim Chesworth Senior Director Regulatory Affairs
    AstraZeneca, United Kingdom
  • Valentina  Strammiello, MA
    Valentina Strammiello, MA Director of Programmes
    European Patients' Forum, Belgium
  • Virginia  Acha, PhD, MSc
    Virginia Acha, PhD, MSc AVP, Global Regulatory Policy
    Merck Sharp & Dohme LLC, United Kingdom
Load More

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.